Home » 幹細胞新聞 » 環境帶來的疾病或傷害 » CIRM grants $6.4 mn Strategic Partnership Award to Sangamo BioSciences to …

“Sangamo’s powerful and precise ZFN-genome editing technology enables modification of a patient’s own stem cells and potentially provides a safer approach to current therapies for haemoglobinopathies such as beta-thalassemia and sickle cell disease," …
[Read more]

Comments are closed.

免費訂閱最新資訊

只需輸入閣下之電郵地址,我們便會向定時你發送本站最新新聞及相關資訊,費用全免。

聯絡我們

Name*

Email*

Tel

Message*

captcha

*require